← All claims

Longevity & Aging · Diets

legume intake decreases cardiovascular disease

In plain terms: Do beans and lentils lower heart disease?

Leans support Longevity & Aging 🔬 Includes disconfirming

Part of: • Aging

RefutedContestedStrong support
consensus score 0.50

Probably modestly yes, but it's only an association and there's no clear link to strokes or heart attacks.

📅 Last reviewed: 2026-07-15

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

11 support 1 contradict 0 tested null 3 mixed · 15 sources, 12 independent groups

What the evidence shows

Higher legume intake is associated with modestly lower CVD/CHD/hypertension/obesity incidence (low-certainty), but shows NO association with stroke, MI, diabetes, or CVD mortality - a Blue-Zones staple whose hard-outcome signal is weak-to-null.

The evidence (15)

SourceGradeStanceQualityFinding
Zhao
2024 · Nutrients
observational supports moderate Scoping review of 30 studies: pulse intake linked to improved lipids, BP, CVD risk and mortality.
Alake
2026 · Nutr Res
animal supports moderate Pinto bean prevented vascular dysfunction via gut microbiome in IL-10-dependent manner in atherogenic-diet mice.
Ferreira
2021 · Crit Rev Food Sci Nutr
meta-analysis supports moderate SR of RCTs: pulse consumption (~150 g/day) improved blood lipids, blood pressure, inflammation markers.
Viguiliouk E, et al. (Sievenpiper)
2019 · Adv Nutr
meta-analysis supports low Umbrella+SRMA 28 cohorts: CVD incidence RR 0.92, CHD 0.90, HTN 0.91, obesity 0.87; null for stroke/MI/diabetes/CVD-mortality (low/very-low GRADE)
Baldeon
2021 · PLoS One
observational supports low PURE Ecuador cross-sectional: higher legume consumption protective against metabolic syndrome and T2D.
Zargarzadeh 2023
2023 · Adv Nutr
meta-analysis mixed moderate legumes lower all-cause/stroke mortality but NO association with CVD/CHD mortality
Mendes 2023
2023 · Nutr Metab Cardiovasc Dis
meta-analysis supports moderate higher legume intake associated with lower CVD/CHD risk
Clark
2021 · Nutr Metab Cardiovasc Dis
RCT supports low Black/red kidney beans induced favorable postprandial vascular responses vs white rice in healthy adults.
Thorisdottir
2023 · Food Nutr Res
meta-analysis contradicts high SR/meta-analysis: legume intake associated with lower CVD risk factors; evidence for hard CVD endpoints limited/low-certainty.
Khairan
2026 · J Nutr
observational mixed moderate Prospective cohort: high soy food intake associated with cardiovascular benefit; AF link explored.
Gaeini Z et al
2026 · study_type: observational
observational mixed moderate Population-Adapted Index (legume substituted for whole grain) T3 vs T1 HR=0.93 (95% CI 0.57-1.50) for incident CVD (composite CHD/stroke/CVD-death); null
Brandt EJ et al
2025 · study_type: observational
observational supports low Legume dietary pattern (PCA-derived) negatively associated with prevalent CVD, β=-0.09 (95% CI -0.15, -0.02); cross-sectional NHANES
Kazemi
2018 · Nutrients
RCT supports moderate Pulse-based diet vs TLC diet in PCOS: greater improvement in insulin response and cardiometabolic measures.
Shaygantabar
2025 · Nutr Rev
meta-analysis supports high RCT meta-analysis: non-soy legumes lowered LDL-C and triglycerides, reducing CVD risk markers.
Bäck S et al
2025 · study_type: RCT
RCT supports moderate 6-wk RCT: legume-for-red-meat substitution lowered total & LDL cholesterol (both p<0.001) and BMI/weight (p=0.009); no clinical CVD event outcome measured

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.